Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe
- Resource Type
- Short Communication
- Source
- In
Clinical Microbiology and Infection September 2024 30(9):1197-1197 - Subject
- Language
- ISSN
- 1198-743X